Cephalon Comments On Study Of Its Leukemia Treatment Led By National Cancer Institute Cooperative Group

Thu, 25 Jan 2007 02:00 PM EST

... Cephalon, Inc. (Nasdaq: CEPH) commented on the announcement today by the National Cancer Institute (NCI) and one of its Cooperative Clinical Trials Groups, the Cancer and Leukemia Group B (CALGB), regarding event-free and overall survival results from a clinical trial using TRISENOX(R) (arsenic trioxide) injection in newly diagnosed patients with acute promyelocytic leukemia (APL). [click link for full article] ...